(Q73505933)
Statements
A phase I dose escalation study of the matrix metalloproteinase inhibitor BAY 12-9566 administered orally in patients with advanced solid tumours (English)
H Hirte
R Goel
P Major
L Seymour
S Huan
D Stewart
J Yau
A Arnold
S Holohan
B Waterfield
S Bates
K Bennett
W Walsh
1 December 2000